Omeprazol Serraclinics (Omeprazole Sodium)

Omeprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions:

• Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis.
• Peptic ulcer disease: supports ulcer healing and reduces recurrence risk.
• Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumors.
• Helicobacter pylori eradication regimens: used as adjunct therapy to improve eradication rates.
• NSAID‑associated ulcer prophylaxis: lowers the risk of ulcer development in high‑risk patients.

• Omeprazole binds covalently to the cysteine residues of the H+/K+‑ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells. This irreversible inhibition blocks the final step of acid secretion, leading to a prolonged reduction in gastric acidity until new pumps are synthesized.

Adverse reactions reported with omeprazole vary in frequency and severity.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually self‑limiting.
• Nausea or vomiting: transient gastrointestinal upset.
• Abdominal pain or flatulence: mild discomfort.
• Constipation: occasional bowel habit change.
• Dry mouth: reduced salivary flow.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis): rash, swelling, airway compromise.
• Clostridioides difficile infection: persistent watery diarrhea.
• Low magnesium levels (hypomagnesemia): muscle cramps, arrhythmia risk.
• Bone fractures: increased risk with long‑term use.
• Vitamin B12 deficiency: anemia, neuropathy with prolonged therapy.
• Acute interstitial nephritis: renal impairment signs.

When prescribing omeprazole, consider the following safety measures:

• Assess renal and hepatic function: dose adjustment may be required in impairment.
• Review concomitant medications: potential for drug‑drug interactions.
• Evaluate need for long‑term therapy: weigh benefits against fracture and infection risk.
• Monitor electrolytes: especially magnesium during extended use.
• Counsel patients on symptom monitoring: report severe abdominal pain or persistent diarrhea.
• Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Omeprazole can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect, may increase cardiovascular events.
• Atazanavir or other protease inhibitors: markedly decreased antiviral exposure.
• Methotrexate (high dose): increased serum concentrations, risk of toxicity.

Moderate Interactions (Monitor Closely)

• Warfarin: potential alteration of INR, require more frequent monitoring.
• Digoxin: modest increase in serum levels, watch for toxicity signs.
• Phenytoin: reduced clearance, may need dose adjustment.
• Iron supplements: decreased absorption, separate dosing times.
• Ketoconazole or other azole antifungals: reduced absorption, consider alternative agents.